Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $16.3750.
Several research analysts have recently weighed in on the company. Keefe, Bruyette & Woods cut their price objective on shares of Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating on the stock in a research report on Friday, November 14th. LADENBURG THALM/SH SH upgraded shares of Crescent Capital BDC to a “strong-buy” rating in a report on Friday, August 15th. Wall Street Zen cut shares of Crescent Capital BDC from a “hold” rating to a “sell” rating in a research note on Saturday, November 15th. Wells Fargo & Company decreased their price objective on shares of Crescent Capital BDC from $15.00 to $14.00 and set an “equal weight” rating for the company in a research report on Friday, November 14th. Finally, Zacks Research upgraded shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research note on Monday.
Get Our Latest Research Report on CCAP
Hedge Funds Weigh In On Crescent Capital BDC
Crescent Capital BDC Stock Performance
Shares of NASDAQ:CCAP opened at $15.02 on Friday. Crescent Capital BDC has a 1-year low of $13.03 and a 1-year high of $20.19. The stock has a market capitalization of $555.59 million, a P/E ratio of 15.33 and a beta of 0.55. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 1.23. The business has a 50-day moving average price of $14.08 and a two-hundred day moving average price of $14.62.
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.46 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.01). Crescent Capital BDC had a return on equity of 9.76% and a net margin of 20.84%.The firm had revenue of $41.35 million for the quarter, compared to the consensus estimate of $42.35 million. Equities analysts predict that Crescent Capital BDC will post 2.09 earnings per share for the current year.
Crescent Capital BDC Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Wednesday, December 31st will be issued a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 11.2%. The ex-dividend date of this dividend is Wednesday, December 31st. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 171.43%.
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
- Five stocks we like better than Crescent Capital BDC
- 3 Healthcare Dividend Stocks to Buy
- Market Momentum: 3 Stocks Poised for Major Breakouts
- How to Calculate Stock Profit
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- Earnings Per Share Calculator: How to Calculate EPS
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.
